Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Gleevec granted FDA approval for first-line treatment of CML

Jan. 2, 2003

Casodex 150 mg not recommended for use in U.S. in early prostate cancer

Jan. 2, 2003

Onconase receives fast track designation for malignant mesothelioma

Jan. 2, 2003

PSMA Development prostate cancer vaccine enters phase I

Jan. 2, 2003

GlycoGenesys acquires Elan's interest in joint venture

Jan. 2, 2003

Novel paclitaxel formulation ABI-007 evaluated in cancer patients

Jan. 2, 2003

Antitumor activity reported for CCI-779 in advanced/metastatic breast cancer

Jan. 2, 2003

Antitumor efficacy of virotherapy plus chemotherapy in gastrointestinal tumors

Jan. 2, 2003

Restrictions on the use of new lung cancer drug

Dec. 30, 2002

Xcytrin enters pivotal trial for treatment of brain metastases in NSCLC patients

Dec. 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...